Importantly, CSF and plasma levels of NfL and p-NfH correlate with ALS severity and progression [48,49,50], and plasma NfL increases up to one year prior to symptomatic onset [51]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.